Assessing a Dose-Response Relationship of Hydralazine and Its Effects on DNA Methyltransferase 1 in Polycystic Kidney Disease Patients

NCT03423810 EARLY_PHASE1 COMPLETED

The purpose of this study is to find a protein (ex. Polycystin 1 or mucin and cadherin like protein) in the urine that is changed after treatment of hydralazine.

Details

Lead sponsor	University of Kansas Medical Center
Phase	EARLY_PHASE1
Status	COMPLETED
Enrolment	14
Start date	Mon Apr 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Jan 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Polycystic Kidney Diseases

Interventions

• Hydralazine

Countries

United States